July 15, 2025

Supplementary Figure S1 from Spatial Transcriptomics Advances the Use of Canine Patients in Cancer Research: Analysis of Osteosarcoma-Bearing Pet Dogs Enrolled in a Clinical Trial

Key Points

MAIN FINDING: The study analyzes quality control parameters in osteosarcoma-bearing pet dogs enrolled in a clinical trial.
KEY EVIDENCE: It presents distributions of sequencing saturation, nuclei, and gene detection metrics among samples.
APPROACH: Quality control parameters were evaluated to understand sequencing performance during spatial transcriptomics.
SIGNIFICANCE: This work supports improved methodologies in canine cancer research, enhancing outcomes in clinical trials.

Abstract

Supplementary Figure 1. The distributions of various quality control parameters including percentages of trimmed, stitched, sequencing saturation, nuclei, and negative counts. Additionally, the distribution of segments with respect to the percentage of genes detected and the total number of genes detected in different percentages of segments are shown.

Supplementary Figure S1 from Spatial Transcriptomics Advances the Use of Canine Patients in Cancer Research: Analysis of Osteosarcoma-Bearing Pet Dogs Enrolled in a Clinical Trial

Key Points

Abstract

Cite This Study